Saar Shapira

Ponatinib reduces viability, migration, and functionality of human endothelial cells

Ayala Gover‐Proaktor, Galit Granot, Saar Shapira et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2016 · 71 citations

Immunology, Cell Death, Cellular Physiology +16

Bosutinib, dasatinib, imatinib, nilotinib, and ponatinib differentially affect the vascular molecular pathways and functionality of human endothelial cells

Ayala Gover‐Proaktor, Galit Granot, Metsada Pasmanik‐Chor et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2018 · 59 citations

Hematological Malignancy, Chronic Myeloid Leukemia, Angiogenesis +15

Deferasirox selectively induces cell death in the clinically relevant population of leukemic CD34+CD38– cells through iron chelation, induction of ROS, and inhibition of HIF1α expression

Saar Shapira, Pia Raanani, Aladin Samara et al. · Experimental Hematology · 2018 · 20 citations · Full text

Redox Signaling, Tumor Biology, Iron Chelation +12

Using natural killer cell‐derived exosomes as a cell‐free therapy for leukemia

Aladin Samara, Michael Anbar, Saar Shapira et al. · Hematological Oncology · 2022 · 17 citations

Second-generation tyrosine kinase inhibitors reduce telomerase activity in K562 cells

Saar Shapira, Galit Granot, Rahav Mor-Tzuntz et al. · Cancer Letters · 2012 · 15 citations

Signal Transduction, Cell Division, Receptor Tyrosine Kinase +5